Haemonetics Corp (HAE)
71.48
+0.32
(+0.45%)
USD |
NYSE |
Nov 01, 16:00
71.45
-0.03
(-0.04%)
After-Hours: 20:00
Haemonetics Revenue (Quarterly): 336.17M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 336.17M |
| March 31, 2024 | 343.29M |
| December 31, 2023 | 336.25M |
| September 30, 2023 | 318.18M |
| June 30, 2023 | 311.33M |
| March 31, 2023 | 304.42M |
| December 31, 2022 | 305.30M |
| September 30, 2022 | 297.48M |
| June 30, 2022 | 261.46M |
| March 31, 2022 | 265.00M |
| December 31, 2021 | 259.77M |
| September 30, 2021 | 239.90M |
| June 30, 2021 | 228.53M |
| March 31, 2021 | 225.03M |
| December 31, 2020 | 240.37M |
| September 30, 2020 | 209.49M |
| June 30, 2020 | 195.58M |
| March 31, 2020 | 238.49M |
| December 31, 2019 | 258.97M |
| September 30, 2019 | 252.57M |
| June 30, 2019 | 238.45M |
| March 31, 2019 | 249.30M |
| December 31, 2018 | 247.36M |
| September 30, 2018 | 241.58M |
| June 30, 2018 | 229.35M |
| Date | Value |
|---|---|
| March 31, 2018 | 233.55M |
| December 31, 2017 | 234.04M |
| September 30, 2017 | 225.38M |
| June 30, 2017 | 210.95M |
| March 31, 2017 | 228.07M |
| December 31, 2016 | 227.84M |
| September 30, 2016 | 220.25M |
| June 30, 2016 | 209.96M |
| March 31, 2016 | 242.34M |
| December 31, 2015 | 233.38M |
| September 30, 2015 | 219.69M |
| June 30, 2015 | 213.41M |
| March 31, 2015 | 226.48M |
| December 31, 2014 | 231.83M |
| September 30, 2014 | 227.58M |
| June 30, 2014 | 224.49M |
| March 31, 2014 | 241.09M |
| December 31, 2013 | 242.12M |
| September 30, 2013 | 235.76M |
| June 30, 2013 | 219.54M |
| March 31, 2013 | 249.94M |
| December 31, 2012 | 247.40M |
| September 30, 2012 | 218.18M |
| June 30, 2012 | 176.48M |
| March 31, 2012 | 186.67M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
195.58M
Minimum
Jun 2020
343.29M
Maximum
Mar 2024
272.37M
Average
261.46M
Median
Jun 2022
Revenue (Quarterly) Benchmarks
| Boston Scientific Corp | 4.209B |
| Baxter International Inc | 3.812B |
| Teleflex Inc | 764.38M |
| Cerus Corp | 46.02M |
| Insulet Corp | 488.50M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 38.37M |
| Total Expenses (Quarterly) | 296.42M |
| EPS Diluted (Quarterly) | 0.74 |
| Enterprise Value | 4.537B |
| Gross Profit Margin (Quarterly) | 52.03% |
| Profit Margin (Quarterly) | 11.41% |
| Earnings Yield | 3.12% |
| Operating Earnings Yield | 4.33% |
| Normalized Earnings Yield | 3.288 |